Provided by Tiger Trade Technology Pte. Ltd.

Sight Sciences, Inc.

8.26
+0.11001.35%
Post-market: 8.260.00000.00%19:30 EDT
Volume:180.59K
Turnover:1.49M
Market Cap:455.03M
PE:-14.85
High:8.35
Open:8.25
Low:8.05
Close:8.15
52wk High:9.24
52wk Low:3.19
Shares:55.09M
Float Shares:37.29M
Volume Ratio:0.52
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5564
EPS(LYR):-0.7369
ROE:-48.42%
ROA:-10.84%
PB:8.60
PE(LYR):-11.21

Loading ...

Sight Sciences announces FDA clearance of Omni Ultra Surgical System

TIPRANKS
·
Aug 05

Sight Sciences Receives FDA 510(k) Clearance of the Omni Ultra Surgical System

THOMSON REUTERS
·
Aug 05

Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

GlobeNewswire
·
Aug 05

Sight Sciences, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Sight Sciences Coverage Assumed by UBS at Buy

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Sight Sciences to $7 From $11, Maintains Buy Rating

MT Newswires Live
·
Jul 28

Sight Sciences to Report Q2 Financial Results After Market Close

Reuters
·
Jul 23

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

GlobeNewswire
·
Jul 23

Sight Sciences is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 08

Sight Sciences price target raised to $6 from $5.15 at Citi

TIPRANKS
·
Jul 08

Citi Keeps Their Hold Rating on Sight Sciences (SGHT)

TIPRANKS
·
Jul 08

Top Executives Quietly Unload Sight Sciences Shares in a Significant Insider Shake-Up

TIPRANKS
·
Jul 07

Insider Confidence Surges as Sight Sciences Director Makes Bold Stock Move

TIPRANKS
·
Jun 12

Sight Sciences director, 10% owner Staffan Encrantz buys 14,100 shares worth $68,793.90

Reuters
·
Jun 12

Sight Sciences Shareholders Reelect Directors, Ratify Auditor

TIPRANKS
·
Jun 06

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
May 29

Sight Sciences price target raised to $5.15 from $4.35 at Citi

TIPRANKS
·
May 28

Sight Sciences Earnings Call Signals Disciplined Growth

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Sight Sciences (SGHT) and Gyre Therapeutics (GYRE)

TIPRANKS
·
May 07

Sight Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07